Related Experiment Video
Updated: Jan 24, 2026

Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current
Published on: November 3, 2020
Quality of Life and Coping in Multiple Endocrine Neoplasia Type 2
Fernanda A Correa1, Evelin C Farias1, Luciana A Castroneves1
1Instituto do Câncer do Estado de São Paulo, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Abstract:
Scarce data are available on the quality of life and psychosocial distress of patients with multiple endocrine neoplasia type 2 (MEN2), a genetic cancer syndrome caused by RET germline mutations. Carriers of RET mutations can face several challenges, including fear for the future, guilt for transmission of a germline mutation to an offspring, side effects of cancer treatment, coping behaviors in the face of a chronic and frequently incurable cancer, and difficulties in access to adequate health care. We have addressed the effects of genetic testing on the quality of life of patients with MEN2 and the lifelong physical and psychosocial challenges experienced by these patients. We have also suggested strategies to minimize the burden of living with this chronic condition and the perspectives on future studies to improve the health-related quality of life of the patients.
Insights
Multiple Endocrine Neoplasia type 2 (MEN2) patients face significant quality of life and psychosocial challenges due to RET mutations. This study explores these burdens and suggests strategies for improvement.
Area of Science:
- Oncology
- Genetics
- Psychology
Background:
- Multiple Endocrine Neoplasia type 2 (MEN2) is a genetic cancer syndrome caused by RET germline mutations.
- Limited data exist on the quality of life and psychosocial distress in MEN2 patients.
- RET mutation carriers experience challenges like fear, guilt, treatment side effects, and healthcare access issues.
Purpose of the Study:
- To investigate the effects of genetic testing on the quality of life for MEN2 patients.
- To identify lifelong physical and psychosocial challenges faced by individuals with MEN2.
- To propose strategies for mitigating the burden of living with MEN2 and suggest future research directions.
Main Methods:
- Review of existing literature on MEN2 patient experiences.
- Analysis of challenges related to genetic testing and chronic cancer management.
- Exploration of coping mechanisms and healthcare access barriers.
Main Results:
- Patients with MEN2 experience significant fear, guilt, and distress related to their genetic condition and cancer.
- Chronic and incurable nature of MEN2-associated cancers presents ongoing physical and psychosocial burdens.
- Access to adequate healthcare and effective coping strategies are crucial for improving patient well-being.
Conclusions:
- Genetic testing and living with MEN2 impose substantial lifelong physical and psychosocial challenges.
- Proactive strategies are needed to minimize the burden of MEN2.
- Further research is essential to enhance the health-related quality of life for MEN2 patients.
Related Concept Videos
Endocrine Signaling
Half-life of a Reaction
The Angiosperm Life Cycle
What is the Endocrine System?
The Endocrine System
Diabetes Mellitus: Type 2 and Gestational

